Clinical Study Results
How many participants had adverse reactions?
There were 47.7% of participants who had adverse reactions during the study that the study
doctors thought were related to the study treatment. This was 398 out of 834 participants.
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
MEDI0382 MEDI0382 MEDI0382 Liraglutide
100 μg 200 μg 300 μg 1.8 mg Placebo
(out of 100 (out of 256 (out of 256 (out of 110 (out of 112
participants) participants) participants) participants) participants)
How many
participants had
46.0% (46) 57.8% (148) 60.5% (155) 22.7% (25) 21.4% (24)
adverse reactions
during the study?
How many
participants had
serious adverse 1.0% (1) 0.4% (1) 0.0% (0) 0.0% (0) 0.9% (1)
reactions during
the study?
How many
participants
stopped 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 1.8% (2)
treatment due to
adverse reactions?
What adverse reactions did the participants have?
The most common adverse reaction during the study was nausea.
The table on the next page shows the adverse reactions that happened in at least 10 participants
during the study. There were other adverse reactions that happened during the study, but those
happened in fewer participants.
9